These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22923993)

  • 41. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering.
    Andreas K; Zehbe R; Kazubek M; Grzeschik K; Sternberg N; Bäumler H; Schubert H; Sittinger M; Ringe J
    Acta Biomater; 2011 Apr; 7(4):1485-95. PubMed ID: 21168535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy.
    Chang LC; Yang CY; Chua AC; Lin YJ; Lai SM
    Mol Pharm; 2011 Oct; 8(5):1767-74. PubMed ID: 21842870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles.
    Meng FT; Ma GH; Qiu W; Su ZG
    J Control Release; 2003 Sep; 91(3):407-16. PubMed ID: 12932718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-step emulsification process for water-in-oil-in-water multiple emulsions stabilized by lamellar liquid crystals.
    Ito T; Tsuji Y; Aramaki K; Tonooka N
    J Oleo Sci; 2012; 61(8):413-20. PubMed ID: 22864511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.
    Kakizawa Y; Nishio R; Hirano T; Koshi Y; Nukiwa M; Koiwa M; Michizoe J; Ida N
    J Control Release; 2010 Feb; 142(1):8-13. PubMed ID: 19804802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation and evaluation of poly(lactic-co-glycolic acid) microspheres loaded with an altered collagen type II peptide for the treatment of rheumatoid arthritis.
    He J; Li H; Liu C; Wang G; Ge L; Ma S; Huang L; Yan S; Xu X
    J Microencapsul; 2015; 32(6):608-17. PubMed ID: 26190213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
    Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
    Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anhydrous reverse micelle lecithin nanoparticles/PLGA composite microspheres for long-term protein delivery with reduced initial burst.
    Chen L; Mei L; Feng D; Huang D; Tong X; Pan X; Zhu C; Wu C
    Colloids Surf B Biointerfaces; 2018 Mar; 163():146-154. PubMed ID: 29291500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microspheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatin.
    Wu J; Wu L; Xu X; Xu X; Yin X; Chen Y; Hu Y
    J Pharm Sci; 2009 Jun; 98(6):2051-8. PubMed ID: 18823006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preparation and properties of Talpha1 loaded injectable sustained release microspheres].
    Zhu Y; Lu Y; Zhong YQ
    Yao Xue Xue Bao; 2007 Feb; 42(2):211-5. PubMed ID: 17518054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled release of a model protein from enzymatically degrading dextran microspheres.
    Franssen O; Stenekes RJ; Hennink WE
    J Control Release; 1999 May; 59(2):219-28. PubMed ID: 10332056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of nano-sized, water-in-oil emulsion as a sustained release formulation of glycyrrhizin.
    Koga K; Nishimon Y; Ueta H; Matsuno K; Takada K
    Biol Pharm Bull; 2011; 34(2):300-5. PubMed ID: 21415545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of antiseptics from the aqueous compartments of a w/o/w multiple emulsion.
    Tedajo GM; Bouttier S; Fourniat J; Grossiord JL; Marty JP; Seiller M
    Int J Pharm; 2005 Jan; 288(1):63-72. PubMed ID: 15607258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
    He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
    Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil.
    Khang G; Kim SW; Cho JC; Rhee JM; Yoon SC; Lee HB
    Biomed Mater Eng; 2001; 11(2):89-103. PubMed ID: 11352116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.